Plasmin releases the anti-tumor peptide from the NC1 domain of collagen XIX - Archive ouverte HAL Access content directly
Journal Articles Oncotarget Year : 2015

Plasmin releases the anti-tumor peptide from the NC1 domain of collagen XIX

(1) , (1) , (1) , (1) , (2) , (1) , (1) , (1) , (1, 3) , (1) , (2) , (1) , (1)
1
2
3

Abstract

During tumor invasion, tumor cells degrade the extracellular matrix. Basement membrane degradation is responsible for the production of peptides with anti-tumor properties. Type XIX collagen is associated with basement membranes in vascular, neuronal, mesenchymal and epithelial tissues. Previously, we demonstrated that the non-collagenous NC1, C-terminal, domain of collagen XIX [NC1(XIX)] inhibits the migration capacities of tumor cells and exerts a strong inhibition of tumor growth. Here, we demonstrate that plasmin, one of the most important enzyme involved in tumor invasion, was able to release a fragment of NC1(XIX), which retained the anti-tumor activity. Molecular modeling studies showed that NC1(XIX) and the antitumor fragment released by plasmin (F4) adopted locally the same type I β-turn conformation. This suggests that the anti-tumor effect is conformation-dependent. This study demonstrates that collagen XIX is a novel proteolytic substrate for plasmin. Such release may constitute a defense of the organism against tumor invasion.
Fichier principal
Vignette du fichier
oncotarget_6_6.pdf (4.07 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

hal-03541824 , version 1 (25-01-2022)

Licence

Attribution - CC BY 4.0

Identifiers

Cite

Jean-Baptiste Oudart, Sylvie Brassart-Pasco, Alexia Vautrin, Christèle Sellier, Carine Machado, et al.. Plasmin releases the anti-tumor peptide from the NC1 domain of collagen XIX. Oncotarget, 2015, 6 (6), pp.3656-3668. ⟨10.18632/oncotarget.2849⟩. ⟨hal-03541824⟩
36 View
5 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More